Dr. Jordan Michael Winter, MD

Dr. Winter practices at University Hospitals Cleveland Medical Center in Cleveland, Ohio, part of University Hospitals Health System.

Dr. Winter's NPI, 1003966920, was assigned on January 11, 2007. Dr. Winter holds Ohio license 35.134614.

Dr. Winter's primary practice is University Hospitals Cleveland Medical Center, at 11100 Euclid Avenue, Cleveland, OH 44106 in Cuyahoga County. The practice phone is (216) 844-1000.

Dr. Winter's primary practice is University Hospitals Cleveland Medical Center in Cleveland, Ohio, part of University Hospitals Health System. Dr. Winter is also affiliated with University Hospitals St. John Medical Center. The medical group on file is University Hospitals Medical Practices. Dmand AI also links Dr. Winter to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Winter practices, 3 sites in all. Vendor and product names are available with a free account.

Surgical oncology is Dr. Winter's primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dmand AI has Dr. Winter's licenses on file in 2 states: Ohio and Pennsylvania.

CMS data shows 31 Medicare services from Dr. Winter across 2 procedure codes in 2021, all of them office visits, for 46 Medicare patients. Medicare paid $1,931 for them. Every service was in an office.

CMS counts 46 Medicare patients who saw Dr. Winter in 2024. The largest group is 65 to 74, with 22 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.49, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Winter's median patient age at 74, with 44% women.

In 2024, Dr. Winter wrote 78 Medicare Part D claims for 30 patients. 77% of them were for generic drugs. CMS names the drug for 37 of them, across 3 drugs with 11 or more claims each, at $49,588 in total drug cost. In 2023, CMS named 12 claims across 1 drug.

Dr. Winter accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Winter as offering telehealth.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 165 papers to Dr. Winter, published from 2011 to 2025. 2022 was the busiest year, with 22. The most frequent topics are Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal and Adenocarcinoma. Dr. Winter has published most often in J Gastrointest Surg. Dr. Winter's most frequent co-authors are Charles J. Yeo, MD, John Brian Ammori, MD and Luke Daniel Rothermel.

Dmand AI links Dr. Winter to 5 clinical trials. 1 is still active or recruiting. Conditions studied include Pancreatic Neoplasms, Pancreatic Diseases and Carcinoma, Acinar Cell. Sidney Kimmel Cancer Center at Thomas Jefferson University sponsors the most, 3.

CMS Open Payments shows 15 general payments to Dr. Winter from 9 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 49% of the total. Celgene Corporation paid the most, $3,563.